These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8998206)
21. Direct-to-the-public advertisement of prescription drugs. Cohen EP N Engl J Med; 1988 Feb; 318(6):373-6. PubMed ID: 3123930 [No Abstract] [Full Text] [Related]
22. The price of seduction: direct-to-consumer advertising of prescription drugs in the US. Marks JH N C Med J; 2003; 64(6):292-5. PubMed ID: 14983622 [No Abstract] [Full Text] [Related]
23. The regulation of prescription drug advertising. Rheinstein RH; Hugstad PS Leg Med Annu; 1978; ():407-19. PubMed ID: 756944 [No Abstract] [Full Text] [Related]
24. Drug firms back-pedal on direct advertising. Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811 [No Abstract] [Full Text] [Related]
25. Europe on the brink of direct-to-consumer drug advertising. Lancet; 2002 May; 359(9319):1709. PubMed ID: 12049853 [No Abstract] [Full Text] [Related]
26. A bitter pill for plaintiffs: obstacles to market theories of causation in prescription drug consumer fraud cases. Arden JD; Brensilver PC Food Drug Law J; 2006; 61(3):539-46. PubMed ID: 17001790 [No Abstract] [Full Text] [Related]
27. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads. Kellerman R; Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544 [No Abstract] [Full Text] [Related]
29. MSJAMA: the rise of direct-to-consumer advertising of prescription drugs in the United States. Huang AJ JAMA; 2000 Nov; 284(17):2240. PubMed ID: 11056599 [No Abstract] [Full Text] [Related]
30. Direct-to-consumer advertising--education or emotion promotion? Wolfe SM N Engl J Med; 2002 Feb; 346(7):524-6. PubMed ID: 11844857 [No Abstract] [Full Text] [Related]
31. The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'. Toop L; Richards D; Dowell T Br J Gen Pract; 2003 Apr; 53(489):342-5. PubMed ID: 12879848 [No Abstract] [Full Text] [Related]
32. Regulating pharmaceutical advertising: what will work? Shapiro MF CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416 [TBL] [Abstract][Full Text] [Related]
33. Direct-to-consumer marketing: how has it fared? Fintor L J Natl Cancer Inst; 2002 Mar; 94(5):329-31. PubMed ID: 11880470 [No Abstract] [Full Text] [Related]
34. Selling prescription drugs to the consumer: with Vioxx's withdrawal, new questions on a $3.8 billion ad business. Elliott S; Ives N N Y Times Web; 2004 Oct; ():C1, C9. PubMed ID: 15487065 [No Abstract] [Full Text] [Related]
35. The new drug marketing: a consumer protection perspective. Woodward D Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733 [No Abstract] [Full Text] [Related]
36. Direct-to-consumer advertising of prescription drugs. Frosch DL; Grande D LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541 [TBL] [Abstract][Full Text] [Related]
38. Examining the FDA's oversight of direct-to-consumer advertising. Gahart MT; Duhamel LM; Dievler A; Price R Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243 [TBL] [Abstract][Full Text] [Related]
39. Direct-to-consumer advertising--where does the public interest lie? Saunders B N Z Med J; 2003 Aug; 116(1180):U557; discussion U557. PubMed ID: 14581978 [No Abstract] [Full Text] [Related]
40. The role of direct-to-consumer advertising. Navarro RP Manag Care Interface; 1998 Nov; 11(11):79-80, 82. PubMed ID: 10187419 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]